Literature DB >> 3666955

Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.

R F Parker1, J K Davis, D K Blalock, R B Thorp, J W Simecka, G H Cassell.   

Abstract

In C57BL/6N and C3H/HeN mice known to be free of all murine pathogens and matched for age, sex, and environmental factors, pulmonary clearance was measured over a 72-h time period after exposure to infectious aerosols of 35S-labeled Mycoplasma pulmonis. Reduced clearance of M. pulmonis in C3H/HeN mice relative to C57BL/6N mice was primarily due to impaired mycoplasmacidal activity in the lungs of the C3H/HeN mice. The C3H/HeN mice also had a slightly slower rate of mechanical transport of radiolabel from the lungs in the first 4 h after infection relative to the C57BL/6N mice but not at any later times. By 72 h after infection (relative to 0 h, C3H/HeN mice had an over 4,000% (1.75 X 10(7) versus 4.30 X 10(5] increase in neutrophils and an over 18,000% (more than 2 orders of magnitude) increase in numbers of M. pulmonis recovered from mechanically disaggregated lungs. In contrast, C57BL/6N mice reduced the number of M. pulmonis present by over 83% (nearly 2 orders of magnitude) before any increase in inflammatory cells, which was only a slight increase in lymphocytes and macrophages at 24 h after infection. These results directly link decreased mycoplasmal pulmonary clearance in C3H/HeN mice with the increased susceptibility to, and severity of, murine respiratory mycoplasmosis observed in this strain. The resistance of C57BL/6N mice appears to be related to nonspecific host defense mechanisms responsible for limiting the extent of infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666955      PMCID: PMC259953          DOI: 10.1128/iai.55.11.2631-2635.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  FACTORS INFLUENCING THE CLEARANCE OF BACTERIA BY THE LUNG.

Authors:  G M GREEN; E H KASS
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations.

Authors:  G W Hunninghake; A S Fauci
Journal:  Cell Immunol       Date:  1976-09       Impact factor: 4.868

3.  Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay.

Authors:  S A Horowitz; G H Cassell
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Leukocytic response to inhaled bacteria.

Authors:  A K Pierce; R C Reynolds; G D Harris
Journal:  Am Rev Respir Dis       Date:  1977-10

5.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

6.  A method for quantitating intrapulmonary bacterial inactivation in individual animals.

Authors:  G M Green; E Goldstein
Journal:  J Lab Clin Med       Date:  1966-10

7.  Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material.

Authors:  J A Juers; R M Rogers; J B McCurdy; W W Cook
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

8.  Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

9.  Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract.

Authors:  J R Lindsey; H Cassell
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307

10.  The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  22 in total

1.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility.

Authors:  P T Rudd; G H Cassell; K B Waites; J K Davis; L B Duffy
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.

Authors:  J M Hickman-Davis; J R Lindsey; S Matalon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

6.  A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection.

Authors:  Amy N Sieve; Karen D Meeks; Sheetal Bodhankar; Suheung Lee; Jay K Kolls; Jerry W Simecka; Rance E Berg
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

7.  Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

Authors:  C B Faulkner; J W Simecka; M K Davidson; J K Davis; T R Schoeb; J R Lindsey; M P Everson
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro.

Authors:  C T Stadtländer; H L Watson; J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.